PDL BioPharma provides Q2 revenue guidance


PDL Biopharma (PDLI +6.1%) says its Q2 top line will come in at $140M which represents ~3% decline yoy but over 4% above the consensus estimate of $134.1M.

From other sites
Comments (3)
  • Donkey Kong
    , contributor
    Comments (184) | Send Message
     
    My screen says +0.8% post-announcement....
    10 Jun 2014, 05:19 PM Reply Like
  • abdullah999
    , contributor
    Comments (838) | Send Message
     
    It's on like Donkey Kong! Sorry, had to be said...
    10 Jun 2014, 05:43 PM Reply Like
  • User 7140591
    , contributor
    Comments (18) | Send Message
     
    It is not up 6%
    11 Jun 2014, 08:25 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs